A Multicenter, Open-Label, Randomised Trial to Compare the Efficacy and Safety of NovoLog Mix 70/30 BID in Combination With Metformin and Pioglitazone to Metformin and Pioglitazone Alone in Insulin Naïve Subjects With Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ACTION
- 20 May 2009 Actual patient numbers amended from 200 to 230 as reported by ClinicalTrials.gov.
- 20 May 2009 Actual end date (1 Aug 2005) added as reported by ClinicalTrials.gov.
- 01 Jan 2009 Results have been published in Diabetes, Obesity and Metabolism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History